Skip to main content
. 2011 Dec 12;1:189. doi: 10.1038/srep00189

Table 1. Significant deregulation of Biocarta pathways in asynchronous Cdc14-null MEFs.

Biocarta pathways Adjusted pvalue (FDR) Genes
Alk Pathway 0.016 Gsk3B, Tcf1, Bmp7, Atf2, Apc, Tgfbr1, Bmp10, Nkx2-5, Chrd, Tgfb1, Gata4, Acvr1, Mef2C, Dvl1, Axin1, Bmpr2, Tgfbr2, Fzd1, Bmpr1a, Tgfbr3, Bmp5, Wnt1, Rfc1, Map3K7, Bmp2, Nppb, Tgfb2, Nppa, Nog, Tgfb3, Bmp4.
G1 pathway 0.071 Gsk3B, Tp53, Cdkn1B, E2F1, Atm, Ccna1, Cdk4, Atr, Cdk6, Dhfr, Tgfb1, Abl1, Cdk2, Tfdp1, Rb1, Cdc25a, Skp2, Ccne1, Hdac1, Tgfb2, Cdkn1a, Cdkn2B, Cdkn2a, Tgfb3, Ccnd1.
Cell Cycle 0.135 Cdkn1B, Rbl1, Ccnb1, Ccnh, E2F1, Ccna1, Cdk4, Cdkn2D, Cdk6, Cdk2, Tfdp1, Cdkn2C, Rb1, Cdc25a, Ccne1, Cdk7, Cdkn1a, Ccnd3, Ccnd2, Cdkn2B, Cdkn2a, Ccnd1.